HR Execs on the Move

Direct Supply

www.directsupply.com

 
Direct Supply offers nearly 1 million essential products for healthcare, foodservice, environmental and furnishings, and theyre all eldercare approved.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Marisa Vancos
Director of Customer Success and Operations Profile
Pamela Koehn
VP Supply Chain, Products Profile
Charles Fastner
Vice President, Product Development & Engineering Profile

Similar Companies

Injex-Equidyne Systems

Injex-Equidyne Systems is a Fullerton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProSomnus

ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.

Chapman Lake Instrument Corp

Chapman Lake Instrument Corp is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ESA Biosciences

ESA Biosciences is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SteadyMed

SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.